Concourse Financial Group Securities’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 360 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2495 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2484 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2538 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2549 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2513 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2540 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2555 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2580 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2520 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2270 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2394 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2361 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2553 |
|
|
2021
Q3 | – | Sell |
-29
| Closed | -$1K | – | 2580 |
|
|
2021
Q2 | $1K | Hold |
29
| – | – | ﹤0.01% | 2259 |
|
|
2021
Q1 | $1K | Sell |
29
-55
| -65% | -$1.9K | ﹤0.01% | 2199 |
|
|
2020
Q4 | $4K | Sell |
84
-36
| -30% | -$1.71K | ﹤0.01% | 1956 |
|
|
2020
Q3 | $4K | Buy |
+120
| New | +$4K | ﹤0.01% | 1834 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2222 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2305 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2220 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1914 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2357 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2382 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2247 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1780 |
|